BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 963170)

  • 21. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A statistical model for the dependence between progression-free survival and overall survival.
    Fleischer F; Gaschler-Markefski B; Bluhmki E
    Stat Med; 2009 Sep; 28(21):2669-86. PubMed ID: 19579225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian modeling of multiple lesion onset and growth from interval-censored data.
    Dunson DB; Holloman C; Calder C; Gunn LH
    Biometrics; 2004 Sep; 60(3):676-83. PubMed ID: 15339290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An early- and late-stage convolution model for disease natural history.
    Pinsky PF
    Biometrics; 2004 Mar; 60(1):191-8. PubMed ID: 15032789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
    Goggins WB; Finkelstein DM; Schoenfeld DA; Zaslavsky AM
    Biometrics; 1998 Dec; 54(4):1498-507. PubMed ID: 9883548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for parametric estimation of the number and size distribution of cell clusters from observations in a section plane.
    de Gunst MC; Luebeck EG
    Biometrics; 1998 Mar; 54(1):100-12. PubMed ID: 9544509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression analysis of doubly censored failure time data with frailty.
    Kim YJ
    Biometrics; 2006 Jun; 62(2):458-64. PubMed ID: 16918909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clustered and interval censored data from a community-based study in asthma.
    Bellamy SL; Li Y; Ryan LM; Lipsitz S; Canner MJ; Wright R
    Stat Med; 2004 Dec; 23(23):3607-21. PubMed ID: 15534894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A time-dependent discrimination index for survival data.
    Antolini L; Boracchi P; Biganzoli E
    Stat Med; 2005 Dec; 24(24):3927-44. PubMed ID: 16320281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stochastic branching model for hemopoietic progenitor cell differentiation.
    Kurnit DM; Matthysse S; Papayannopoulou T; Stamatoyannopoulos G
    J Cell Physiol; 1985 Apr; 123(1):55-63. PubMed ID: 3972912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of interval-censored longitudinal data with application to onco-haematology.
    De Lorenzo P; Henderson R; Valsecchi MG
    Stat Med; 2005 Dec; 24(24):3945-57. PubMed ID: 16320268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation and reliability of molecular sequence alignments.
    Thorne JL; Churchill GA
    Biometrics; 1995 Mar; 51(1):100-13. PubMed ID: 7766767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing influence in regression analysis with censored data.
    Escobar LA; Meeker WQ
    Biometrics; 1992 Jun; 48(2):507-28. PubMed ID: 1637975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-to-event analysis with artificial neural networks: an integrated analytical and rule-based study for breast cancer.
    Lisboa PJ; Etchells TA; Jarman IH; Hane Aung MS; Chabaud S; Bachelot T; Perol D; Gargi T; Bourdès V; Bonnevay S; Négrier S
    Neural Netw; 2008; 21(2-3):414-26. PubMed ID: 18304780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint analysis of time-to-event and multiple binary indicators of latent classes.
    Larsen K
    Biometrics; 2004 Mar; 60(1):85-92. PubMed ID: 15032777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes.
    Bureau A; Shiboski S; Hughes JP
    Stat Med; 2003 Feb; 22(3):441-62. PubMed ID: 12529874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximum likelihood estimation in the joint analysis of time-to-event and multiple longitudinal variables.
    Lin H; McCulloch CE; Mayne ST
    Stat Med; 2002 Aug; 21(16):2369-82. PubMed ID: 12210621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.